The drug dimethyltriptamine (DMT) is to be used in a trial as a possible treatment for depression.
The psychedelic, which Trainspotting author Irvine Welsh has spoken of taking, will be used along with a psychotherapy session to see its effects.
It's reported DMT will first be given to people not suffering with depression, before then being given to those who are suffering with depression.
Read this next: The magic mushroom renaissance
Small Pharma is running the trial alongside Imperial College London. Small Pharma's chief scientific and medical officer Carol Routledge said: “The psychedelic drug breaks up all of the ruminative thought processes in your brain – it literally undoes what has been done by either the stress you’ve been through or the depressive thoughts you have – and hugely increases the making of new connections.
“Then the [psychotherapy] session afterwards is the letting-things-settle piece of things – it helps you to make sense of those thoughts and puts you back on the right track. We think this could be a treatment for a number of depressive disorders besides major depression, including PTSD, treatment-resistant depression, obsessive-compulsive disorder, and possibly some types of substance abuse.”
It's not a first for Class A drugs being used in clinical trials. Scientists have tested MDMA's impact as a treatment for post-traumatic stress disorder.
Scientists have also recommended taking MDMA to deal with the effects of the coronavirus-caused lockdown.
[Photo: Lindsay Cameron and Lee Dunlap]
Dave Turner is Mixmag's Commercial Content Editor, follow him on Twitter